January  29,  2010
Maria Stecklein Flynn of Orbis Biosciences featured in the Kansas City Business Journal Link to story
December  22,  2009
Brooks Morgan of Infegy featured in the Wall Street Journal Link to story
December  3,  2009
Proteon Therapeutics Named 2010 Technology Pioneer by the World Economic Forum Link to press release
November  23,  2009
Proteon Therapeutics initiates second Phase I/II clinical trial Link to story
October  9,  2009
Science magazine profiles Orbis Biosciences founder Cory Berkland Link to story
October  6,  2009
LightSpeed Genomics receives grant from the National Human Genome Research Institute Link to story
October  5,  2009
Advertising Age reports on new insights illuminated by Infegys SocialRadar technology Link to story
October  1,  2009
Orbis Biosciences presents at Yet2.coms Executive Briefing Link to summary
August  27,  2009
Infegy launches major update to its industry leading social media software toolset Link to press release
July  2,  2009
Silicon Prairie News interviews Infegy co-founder Adam Coomes Link to video
June  29,  2009
Proteon Therapeutics named to FierceBiotechs "2009 Fierce 15" Link to story
June  5,  2009
Proteon Therapeutics founders Nick Franano and Bill Whitaker honored as Ernst & Young Entrepreneurs of the Year Link to story
May  28,  2009
Bessemer Ventures and Devon Park join Proteon Therapeutics investor syndicate as Series B financing reaches $50 million; FDA grants orphan drug status to first drug candidate Link to story
April  20,  2009
Proteon founders named as finalists for the Ernst & Young entrepreneur of the year award Link to story
March  30,  2009
Orbis Biosciences and Infegy profiled in the Kansas City Business Journal; both companies succeeding despite tough economy Link to story
March  5,  2009
Proteon Therapeutics raises $38 million B-round financing; Enters into option agreement to be acquired by Novartis for up to $550 million Link to story
February  27,  2009
Orbis Biosciences selected to demonstrate at Worlds Best Technology Showcase Link to website
January  23,  2009
Maria Stecklein of Orbis Biosciences selected for KTEC Pipeline program Link to story
November  10,  2008
Infegy to demonstrate SocialRadar at ad:tech New York Link to conference website
October  21,  2008
Rockhill Partners leads investment in Orbis Biosciences Link to website
October  13,  2008
Proteon Therapeutics to present new data on its lead drug candidate, PRT-201 Link to story
September  10,  2008
Proteon Therapeutics receives Food and Drug Administration fast track designation for its lead drug candidate Link to press release
May  7,  2008
Proteon co-founders named as finalists for the Ernst & Young Entrepreneur Of The Year Award Link to press release
April  4,  2008
Mass High Tech News profiles Proteon CEO Tim Noyes and his efforts to "put the band back together" after $1 billion exit with GelTex Link to story
March  12,  2008
Biopharma veteran Gregory Phelps joins the Board of Proteon Therapeutics Link to press release
March  12,  2008
Proteon Therapeutics receives European patent covering new method of dilating veins and arteries Link to press release
February  13,  2008
Proteon Therapeutics founder testifies before Congress on the importance of the SBIR in advancing innovation Link to testimony
November  10,  2007
Solametrix changes its name to LightSpeed Genomics Link to new website
October  31,  2007
Proteon Therapeutics to present at the Annual Meeting of the American Society of Nephrology Download article (pdf)
September  10,  2007
Proteon Therapeutics closes new $12 million financing; Mark Fitzpatrick joins company as CFO Downloard article (pdf)
April  4,  2007
Missouri Governor Matt Blunt tours Proteon Therapeutics new Kansas City lab; company on track to raise $12 million in new financing Link to story
January  23,  2007
Proteon Therapeutics receives second U.S. patent broadly covering elastase vasodilatation Download article (pdf)
January  10,  2007
Rockhill Partners completes investment in Solametrix Link to website
September  12,  2006
Proteon Therapeutics adds experienced research and drug development talent to its team Download article (pdf)
June  26,  2006
Proteon Therapeutics receives U.S. patent broadly covering new method of artery and vein dilation Download article (pdf)
June  21,  2006
Proteon Therapeutics selects QSV Biologicals, Ltd for PRT-201 manufacturing Download article (pdf)
May  10,  2006
Proteon Therapeutics hires veteran biotechnology executive Timothy Noyes as CEO Download article (pdf)
April  20,  2006
Red Herring examines Proteon Therapeutics drug pipeline Link to story
March  29,  2006
Proteon Therapeutics closes $19 million financing Downloard article (pdf)
January  13,  2006
Rockhill Partners completes follow-on investment in Proteon Therapeutics Download article (pdf)
January  31,  2005
Rockhill Partners completes investment in Proteon Therapeutics
designed & developed by artsandlogos.com